BREAKING: Abbott completes $20B senior notes offering to fund the Exact Sciences takeover — $ABT $EXAS…
Filed with the SEC on · Summarized by InvestorsBot
BREAKING: Abbott completes $20B senior notes offering to fund the Exact Sciences takeover — $ABT $EXAS 🚨💰 #BREAKING #Mergers #Biotech #FinTwit
ALERT: Proceeds will fund the Exact Sciences acquisition, repay Exact debt & cover fees — this materially ups $ABT’s leverage. If deal not closed by the End Date, Abbott must redeem notes at 101% + interest ⚠️📈 #Debt #InvestorAlert #Mergers #FinTwit
CONFIRMED: Notes load = $20B across maturities (floating + 2029–2066); coupons ~3.7%–5.6% (long bonds 2056@4.65%/5.5%? check prospectus). Issued under Feb 23 pricing deal — watch credit & interest expense impact 🧾🔍 #BondMarket #Credit #Stocks #FinTwit
Next steps: Abbott using net proceeds + cash/borrowings to close Merger Agreement (dated Nov 19, 2025). End Date ~Feb 17, 2027 (or as extended). If Abbott walks or deal lapses, mandatory redemption triggers — monitor filings/rating action 📅🔎 $ABT $EXAS #ExactSciences #M&A #FinTwit